ANAPC13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.225000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.852600E-01
Normal-vs-Stage2
6.169400E-01
Normal-vs-Stage3
2.521400E-01
Normal-vs-Stage4
7.974000E-01
Stage1-vs-Stage2
8.493600E-02
Stage1-vs-Stage3
4.166400E-02
Stage1-vs-Stage4
4.985800E-01
Stage2-vs-Stage3
3.562600E-01
Stage2-vs-Stage4
4.107000E-01
Stage3-vs-Stage4
1.504590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.936000E-01
Normal-vs-AfricanAmerican
9.881800E-01
Normal-vs-Asian
8.964000E-01
Caucasian-vs-AfricanAmerican
5.667000E-01
Caucasian-vs-Asian
6.382400E-01
AfricanAmerican-vs-Asian
8.637400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.194200E-01
Normal-vs-Female
8.611000E-01
Male-vs-Female
2.105400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.364600E-01
Normal-vs-Age(41-60Yrs)
7.966800E-01
Normal-vs-Age(61-80Yrs)
6.774600E-01
Normal-vs-Age(81-100Yrs)
9.118400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.114000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.657800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.805800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.339800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.022200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.374800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.272400E-01
Normal-vs-Daily Drinker
4.537000E-01
Normal-vs-Weekly Drinker
5.914200E-01
Normal-vs-Occasional Drinker
7.144400E-01
Normal-vs-Social Drinker
8.125000E-01
Non Drinker-vs-Daily Drinker
4.904400E-01
Non Drinker-vs-Weekly Drinker
5.565800E-01
Non Drinker-vs-Occasional Drinker
2.593400E-01
Non Drinker-vs-Social Drinker
1.733780E-01
Daily Drinker-vs-Weekly Drinker
9.609600E-01
Daily Drinker-vs-Occasional Drinker
5.955800E-01
Daily Drinker-vs-Social Drinker
4.208200E-01
Weekly Drinker-vs-Occasional Drinker
7.113200E-01
Weekly Drinker-vs-Social Drinker
5.608400E-01
Occasional Drinker-vs-Social Drinker
8.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.462100E-02
Normal-vs-Grade 2
1.717740E-03
Normal-vs-Grade 3
5.864700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.238600E-01
Grade 1-vs-Grade 3
8.431600E-01
Grade 1-vs-Grade 4
3.462100E-02
Grade 2-vs-Grade 3
6.750000E-01
Grade 2-vs-Grade 4
1.717740E-03
Grade 3-vs-Grade 4
5.864700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.258800E-01
Normal-vs-NonDiabetic
6.611200E-01
Diabetic-vs-NonDiabetic
6.347400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.838000E-01
Normal-vs-NoPancreatitis
6.473600E-01
Pancreatitis-vs-NoPancreatitis
5.275000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.272400E-01
Normal-vs-N1
6.835400E-01
N0-vs-N1
6.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.534800E-01
Normal-vs-TP53-NonMutant
8.408400E-01
TP53-Mutant-vs-TP53-NonMutant
8.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
